ESC Premium Access

Outcome of patients with heart failure and mid-range ejection fraction after transcatheter aortic valve implantation (TAVI)

Congress Presentation

About the speaker

Doctor Ulrich Fischer-Rasokat

Kerckhoff Heart and Thorax Center, Bad Nauheim (Germany)
0 follower

13 more presentations in this session

Psoas muscle area and volume and frailty scoring as predictors of outcomes after transcatheter aortic valve implantation

Speaker: Professor P. Kleczynski (Krakow, PL)


Changes in valvulo-arterial impedance after transcatheter aortic valve implantation according to calcification burden of thoracic aorta

Speaker: Doctor T. Gegenava (Tbilisi, GE)


Impact of serum hemoglobin level at discharge on long-term survival in patients undergoing transcatheter aortic valve implantation for severe aortic stenosis: an observational cohort study.

Speaker: Doctor M. Okamoto (Bernau bei Berlin, DE)


Durability and clinical outcomes at 5 to 9 years following transcatheter aortic valve implantation

Speaker: Doctor A. Munoz Garcia (Malaga, ES)


Impact of new onset atrial fibrillation on outcome of patients undergoing transfemoral transcatheter aortic valve replacement

Speaker: Mr R. Hoellriegel (Dresden, DE)


Access the full session

Poster Session 5 - Deep dive in TAVI

Speakers: Doctor U. Fischer-Rasokat, Professor P. Kleczynski, Doctor T. Gegenava, Doctor M. Okamoto, Doctor A. Munoz Garcia...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb